In response to the rapid spread of the new coronavirus SARS-CoV-2, Bethyl Laboratories has developed ELISA kits for the detection of human IgG and IgM antibodies against the virus in serum or plasma to aid vaccine and other COVID-19 related research.
Using an ELISA to detect SARS-CoV-2 antibodies is typically considered a more efficient choice than a lateral flow immunoassay, which is commonly used for clinical diagnostics due to the speed at which they can be performed. ELISA is also the more sensitive of the two assays.
Together we can accelerate discovery to improve lives.
Detect your protein of interest with confidence using our ELISA kits. Every antibody that Bethyl sells has been manufactured and validated on-site to ensure high quality standards and reliable results. Select from an array of milk and serum proteins from many species and explore the assortment accessories – from solutions to buffers, and more – to support your most challenging research needs.
Quickly detect multiple antigens in a single tissue section to gain clear understanding of the microenvironment without compromising samples. To serve your multiplex research needs, Bethyl introduces IHC PathPlex® panels to profile the complex tumor microenvironment. Each antibody has been validated for IHC and utilized in a multiplex format by our own scientists via proprietary processes to ensure the highest quality.
Trial sizes are ideal for comparisons between suppliers or various application testings and cost effective at $99 US. Over 6,000 trial-sized antibodies are available to more than 3,300 protein targets, and new releases are continuing to be added every month.
Bethyl's purpose is to improve lives by supporting scientific discovery. This drives our complete dedication to the highest standards of product and service quality.